XBIO
Xenetic Biosciences Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2013 | Aug 2013 | Dec 2012 | Aug 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | ||||||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing | ||||||||||||||
| Capital Expenditures | — | — | — | — | — | — | — | 0 | 9,264 | 16,793 | 78,634 | 212,500 | 130,084 | — |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing | ||||||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Summary | ||||||||||||||
| Free Cash Flow | — | — | — | — | — | — | — | -6.5M | 1.5M | -8.8M | -6.1M | 68,109 | -6.4M | — |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |